Childhood-onset systemic lupus erythematosus – A case report
DOI:
https://doi.org/10.66344/jpad.v26i1.80Keywords:
Systemic lupus erythematosus, childhood-onset SLEAbstract
Systemic lupus erythematosus (SLE) is autoimmune multisystem disease associated with various clinical manifestations. Childhood-onset SLE (cSLE) is extremely rare and comprises only 15-20% of lupus erythematosus cases. Most of the children belong to the adolescent group while very few are in the prepubertal age. We herein, report a case of 7-year-old female child diagnosed as systemic lupus erythematosus due to its rare occurrence in pediatric age group.
References
1. Cassidy JT. SLE, Juvenile dermatomyositis, Scleroderma, and Vasculitis. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of Rheumatology, 4th edn. Philadelphia, WB Saunders; 1993. P. 1224-47.
2. Ali VS, Dalvi AS, Merchant RH, Mehta KP, Chadlani AT, Badakere SS et al. Systemic lupus erythematosus in Indian children. Indian J Pediatr. 1989;26:868-73.
3. Chandrashekharan AN, Rajendra CP, Ramakrishnan S, Madhavan R, Pratibhan M. Childhood systemic lupus erythematosus in south India. Indian J Pediatr. 1994;61:223-9.
4. Lehman TJ, McCurdy D, Spencer C. Prognostic value of antibodies to Ro/SSA, SSB/La, and RNP in children with systemic lupus erythematosus (abstract). Arthritis Rheum. 1990;33(Suppl):S154.
5. Segel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum. 1973;3:154.
6. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1994;34:866-72.
7. Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003;25:3-12.
8. Von Feldt JM. Systemic lupus erythematosus. Recognizing its various presentations. Postgrad Med. 1995;97: 79, 83, 86.
9. Pande J, Sekharan NG, Kailash S, Uppal SS, Singh RR, Kumar A et al. Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults. Lupus. 1993;2:83-7.
10. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus. A comparison of onset, clinical features, serology and outcome. Br J Rheumatol. 1995;34:866-72.
11. Janwityanujit S, Totemchokchyakarn K, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Age related differences on clinical and immunological manifestations of SLE. Asian Pac J Allergy Immunol. 1995;13:145-9.
12. Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jiménez S et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological in 35 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998;57:456-9.
13. Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus. 2011;15:1345-55. doi: 10.1177/0961203311416694.
14. Quintero-Del-Rio Al, Van Miller. Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol. 2000;15:803-7.
15. Carreno L, Lopez-Longo FJ, Monteagudo I et al. Immunological and clinical differences between juvenile and adult onset systemic lupus erythematosus. Lupus. 1999;8:287-92.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Amit Kumar, Pradeep Kumar, Masuma P Bhengra, Prabhat Kumar, Syam Sundar Chaudhary
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
